[go: up one dir, main page]

FI961999L - Farmaseuttinen emulsio - Google Patents

Farmaseuttinen emulsio Download PDF

Info

Publication number
FI961999L
FI961999L FI961999A FI961999A FI961999L FI 961999 L FI961999 L FI 961999L FI 961999 A FI961999 A FI 961999A FI 961999 A FI961999 A FI 961999A FI 961999 L FI961999 L FI 961999L
Authority
FI
Finland
Prior art keywords
pharmaceutical emulsion
emulsion
pharmaceutical
Prior art date
Application number
FI961999A
Other languages
English (en)
Swedish (sv)
Other versions
FI961999A0 (fi
FI116999B (fi
Inventor
Kjell Hjalmar Andersson
Eva Kristina Byroed
Anna-Carin Hansson
Margareta Nordlander
Rolf Christer Westerlund
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI961999L publication Critical patent/FI961999L/fi
Publication of FI961999A0 publication Critical patent/FI961999A0/fi
Application granted granted Critical
Publication of FI116999B publication Critical patent/FI116999B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI961999A 1993-11-12 1996-05-10 Menetelmä farmaseuttisen emulsion valmistamiseksi FI116999B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9303744A SE9303744D0 (sv) 1993-11-12 1993-11-12 Pharmaceutical emulsion
SE9303744 1993-11-12
SE9401032 1994-03-28
PCT/SE1994/001032 WO1995013066A1 (en) 1993-11-12 1994-11-03 Pharmaceutical emulsion

Publications (3)

Publication Number Publication Date
FI961999L true FI961999L (fi) 1996-05-10
FI961999A0 FI961999A0 (fi) 1996-05-10
FI116999B FI116999B (fi) 2006-05-15

Family

ID=20391731

Family Applications (1)

Application Number Title Priority Date Filing Date
FI961999A FI116999B (fi) 1993-11-12 1996-05-10 Menetelmä farmaseuttisen emulsion valmistamiseksi

Country Status (30)

Country Link
US (1) US5739152A (fi)
EP (1) EP0727997B1 (fi)
JP (1) JP3759951B2 (fi)
KR (1) KR100345627B1 (fi)
CN (1) CN1072934C (fi)
AT (1) ATE213158T1 (fi)
AU (1) AU678650B2 (fi)
CA (1) CA2176360C (fi)
CZ (1) CZ290772B6 (fi)
DE (1) DE69429871T2 (fi)
DK (1) DK0727997T3 (fi)
EE (1) EE03223B1 (fi)
EG (1) EG20764A (fi)
ES (1) ES2172572T3 (fi)
FI (1) FI116999B (fi)
HU (1) HU223142B1 (fi)
IL (1) IL111345A (fi)
IS (1) IS2036B (fi)
MY (1) MY121201A (fi)
NO (1) NO314877B1 (fi)
NZ (1) NZ276197A (fi)
PL (1) PL181462B1 (fi)
PT (1) PT727997E (fi)
RU (1) RU2144358C1 (fi)
SA (1) SA94150314B1 (fi)
SE (1) SE9303744D0 (fi)
SK (1) SK283271B6 (fi)
UA (1) UA40633C2 (fi)
WO (1) WO1995013066A1 (fi)
ZA (1) ZA948180B (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030158220A1 (en) * 1997-11-03 2003-08-21 Foss Joseph F. Use of methylnaltrexone and related compounds to treat chronic opioid use side effects
ES2216517T3 (es) * 1998-05-29 2004-10-16 Skyepharma Canada Inc. Composiciones de microcapsulas termoprotegidas y procedimiento para su esterilizacion terminal con vapor.
SE9804002D0 (sv) * 1998-11-23 1998-11-23 Astra Ab New manufacturing process
DE10036871A1 (de) 2000-07-28 2002-02-14 Pharmasol Gmbh Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
BR0210994A (pt) 2001-06-15 2004-06-08 Cornerstone Pharmaceuticals Compostos farmacêuticos e de diagnósticos contendo nanopartìculas úteis para tratamento de tecidos e células
HRP20150037T4 (hr) * 2003-04-08 2022-09-02 Progenics Pharmaceuticals, Inc. Farmaceutske formulacije koje sadrže metilnaltrekson
AR057035A1 (es) * 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
AR057325A1 (es) * 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
TWI489984B (zh) 2006-08-04 2015-07-01 Wyeth Corp 用於非經腸道傳輸化合物之配方及其用途
TW200817048A (en) * 2006-09-08 2008-04-16 Wyeth Corp Dry powder compound formulations and uses thereof
CL2008000905A1 (es) * 2007-03-29 2008-08-22 Progenics Pharm Inc Compuestos derivados de morfina, antagonistas del receptor opioide periferico; metodo de preparacion; composicion farmaceutica; y uso para reducir los efectos de la actividad opioide endogena.
CA2865389A1 (en) 2007-03-29 2008-10-09 Progenics Pharmaceuticals, Inc. Crystal forms and uses thereof
SI2139890T1 (sl) 2007-03-29 2014-12-31 Wyeth Llc Antagonisti perifernih opioidnih receptorjev in njih uporaba
WO2009099411A1 (en) * 2008-02-06 2009-08-13 Progenics Pharmaceuticals, Inc. Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone
BRPI0916936B8 (pt) * 2008-08-01 2021-05-25 Chiesi Farm Spa composições farmacêuticas, uso de clevidipina e método de reduzir impurezas.
HUE047692T2 (hu) * 2008-08-01 2020-05-28 Chiesi Farm Spa Gyógyászati készítmények és eljárások stabilizálásukra
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
US9034389B2 (en) * 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
JP6081058B2 (ja) * 2009-03-19 2017-02-15 第一三共株式会社 包装により安定保存された固形製剤
CN101780036B (zh) * 2010-03-30 2011-11-16 武汉武药科技有限公司 丁酸氯维地平脂微球注射液及其制备方法
US8658676B2 (en) * 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
EP2627173B2 (en) * 2010-10-12 2018-07-04 Chiesi Farmaceutici S.p.A. Clevidipine emulsion formulations containing antimicrobial agents
CN102531998A (zh) * 2010-12-09 2012-07-04 天津药物研究院 α型多晶型丁酸氯维地平结晶、其制备方法、用途和药物组合物
CN102525918A (zh) * 2010-12-30 2012-07-04 天津药物研究院 一种丁酸氯维地平的脂肪乳注射液及其制备工艺
US20120213855A1 (en) * 2011-02-17 2012-08-23 Cima Labs Inc. Dosage forms for weakly ionizable compounds
AU2012236332A1 (en) * 2011-04-01 2013-10-31 Chiesi Farmaceutici S.P.A. Short -acting dihydropyridines (clevidipine) for use in reducing stroke damage
KR102009698B1 (ko) 2011-12-20 2019-08-13 바이옴 테라퓨틱스 리미티드 진균 감염의 치료를 위한 국소 오일 조성물
MX359768B (es) 2012-10-26 2018-10-10 Chiesi Farm Spa Métodos para controlar la presión arterial y para reducir la disnea durante una insuficiencia cardiaca.
CN103110580B (zh) * 2013-02-20 2014-09-17 北京德立福瑞医药科技有限公司 丁酸氯维地平注射剂
AU2014252157B2 (en) * 2013-04-12 2017-05-11 Vyome Therapeutics Limited Composition and formulation of antimicrobial agents, processes thereof and methods for treating microbial infections
ES2950154T3 (es) 2014-05-19 2023-10-05 Chiesi Farm Spa Nanopartículas de clevidipino y composiciones farmacéuticas de las mismas

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3315805A1 (de) * 1983-04-30 1984-11-08 Bayer Ag, 5090 Leverkusen Wirkstoffzubereitungen
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
DE3515335C2 (de) * 1985-04-27 1995-01-26 Bayer Ag Arzneizubereitung enthaltend Dihydropyridine und Verfahren zu ihrer Herstellung
DE4217842A1 (de) * 1992-05-29 1993-12-02 Dietl Hans Calciumantagonisten enthaltende pharmazeutische Zubereitung zur intravenösen und intrakoronaren Applikation sowie Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
EP0727997B1 (en) 2002-02-13
WO1995013066A1 (en) 1995-05-18
AU678650B2 (en) 1997-06-05
ES2172572T3 (es) 2002-10-01
NO961898D0 (no) 1996-05-10
CN1136774A (zh) 1996-11-27
NO314877B1 (no) 2003-06-10
MY121201A (en) 2006-01-28
CA2176360A1 (en) 1995-05-18
KR100345627B1 (ko) 2003-03-15
RU2144358C1 (ru) 2000-01-20
HK1013261A1 (en) 1999-08-20
ZA948180B (en) 1995-05-12
HUT74474A (en) 1996-12-30
UA40633C2 (uk) 2001-08-15
US5739152A (en) 1998-04-14
JPH09505045A (ja) 1997-05-20
DK0727997T3 (da) 2002-04-22
PL181462B1 (pl) 2001-07-31
DE69429871D1 (de) 2002-03-21
CN1072934C (zh) 2001-10-17
HU223142B1 (hu) 2004-03-29
AU1037195A (en) 1995-05-29
CZ290772B6 (cs) 2002-10-16
CZ133896A3 (en) 1996-09-11
EG20764A (en) 2000-01-31
IS4224A (is) 1995-05-13
NZ276197A (en) 1997-04-24
IS2036B (is) 2005-08-15
FI961999A0 (fi) 1996-05-10
NO961898L (no) 1996-06-25
SK283271B6 (sk) 2003-04-01
IL111345A0 (en) 1994-12-29
ATE213158T1 (de) 2002-02-15
PL314263A1 (en) 1996-09-02
FI116999B (fi) 2006-05-15
JP3759951B2 (ja) 2006-03-29
IL111345A (en) 2000-08-31
EE03223B1 (et) 1999-10-15
PT727997E (pt) 2002-07-31
DE69429871T2 (de) 2002-08-22
SK59796A3 (en) 1996-12-04
SA94150314B1 (ar) 2005-06-14
CA2176360C (en) 2005-08-23
EP0727997A1 (en) 1996-08-28
SE9303744D0 (sv) 1993-11-12
HU9601268D0 (en) 1996-07-29

Similar Documents

Publication Publication Date Title
FI961999L (fi) Farmaseuttinen emulsio
NO975321D0 (no) Farmasöytisk emulsjon omfattende fluorforbindelser
FI961525L (fi) Uusi emulsioformulaatio
FI930882A0 (fi) Farmaceutiska foereningar
FI963064L (fi) Öljy-vedessä-emulsiot
FI973243L (fi) Uusi farmaseuttinen yhdistelmä
BR9301188A (pt) Emulsao de betume
FI944832A0 (fi) Farmaseuttinen koostumus
BR9610396A (pt) Formulação farmacêutica
FI931162A7 (fi) Vesi-öljyssä-emulsioita
NO931831D0 (no) Farmasoeytiske blandinger
DE69306339D1 (de) Emulsionszusammensetzung
BR9400965A (pt) Emulsão explosiva
FI934690A7 (fi) Elinspesifinen emulsio
NO952521D0 (no) Fluorkarbonemulsjoner
DE69220157D1 (de) Emulsionssprengstoff
BR9610214A (pt) Compostos farmacéuticos
DE69628629D1 (de) Emulsionszusammensetzung
NO934145D0 (no) Farmas!ytiske forbindelser
FI931251A0 (fi) Farmaceutiska foereningar
FI955433L (fi) Öljy-vedessä -emulsio
NO961589D0 (no) Farmasöytiske blandinger
FI973230A0 (fi) Uusi farmaseuttinen formulaatio
FI950942L (fi) Farmaseuttisia emulsioita, jotka sisältävät bioaktiivisia steroideja
NO965448L (no) Farmasöytiske forbindelser

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 116999

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: ASTRAZENECA AB

Free format text: ASTRAZENECA AB

MA Patent expired